AmgenWe'll start big, with $66 billion pharma firm Amgen (AMGN - Get Report). Amgen has been a strong performer in the last year, rallying more than 28% over the trailing 12 months. But that rally may be far from over if the price setup in shares holds true.
4 Breakout Buys for January -- and One Sell
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts